These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31582723)

  • 21. Use of an Alzheimer's disease polygenic risk score to identify mild cognitive impairment in adults in their 50s.
    Logue MW; Panizzon MS; Elman JA; Gillespie NA; Hatton SN; Gustavson DE; Andreassen OA; Dale AM; Franz CE; Lyons MJ; Neale MC; Reynolds CA; Tu X; Kremen WS
    Mol Psychiatry; 2019 Mar; 24(3):421-430. PubMed ID: 29487403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.
    Tan CH; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Dillon WP; Bonham LW; Yokoyama JS; Karch CM; Brewer JB; Rabinovici GD; Miller BL; Schellenberg GD; Kauppi K; Feldman HA; Holland D; McEvoy LK; Hyman BT; Bennett DA; Andreassen OA; Dale AM; Desikan RS;
    Acta Neuropathol; 2018 Jan; 135(1):85-93. PubMed ID: 29177679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polygenic hazard scores in preclinical Alzheimer disease.
    Tan CH; Hyman BT; Tan JJX; Hess CP; Dillon WP; Schellenberg GD; Besser LM; Kukull WA; Kauppi K; McEvoy LK; Andreassen OA; Dale AM; Fan CC; Desikan RS
    Ann Neurol; 2017 Sep; 82(3):484-488. PubMed ID: 28940650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.
    Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Kenney AE; Gross CJ; Taub ES; Plassman BL; Fisher GG
    Neuropsychology; 2013 Jan; 27(1):86-94. PubMed ID: 23356599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
    Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
    Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease.
    Chaudhury S; Patel T; Barber IS; Guetta-Baranes T; Brookes KJ; Chappell S; Turton J; Guerreiro R; Bras J; Hernandez D; Singleton A; Hardy J; Mann D; ; Morgan K
    Neurobiol Aging; 2018 Feb; 62():244.e1-244.e8. PubMed ID: 29103623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms.
    Lin YF; Smith AV; Aspelund T; Betensky RA; Smoller JW; Gudnason V; Launer LJ; Blacker D
    Alzheimers Dement; 2019 Jan; 15(1):65-75. PubMed ID: 30240575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
    Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
    BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease.
    Daunt P; Ballard CG; Creese B; Davidson G; Hardy J; Oshota O; Pither RJ; Gibson AM
    J Prev Alzheimers Dis; 2021; 8(1):78-83. PubMed ID: 33336228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data.
    Gibson J; Russ TC; Adams MJ; Clarke TK; Howard DM; Hall LS; Fernandez-Pujals AM; Wigmore EM; Hayward C; Davies G; Murray AD; Smith BH; Porteous DJ; Deary IJ; McIntosh AM
    Transl Psychiatry; 2017 Apr; 7(4):e1094. PubMed ID: 28418403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Pace of Aging Measured by Blood-Based DNA Methylation With Age-Related Cognitive Impairment and Dementia.
    Sugden K; Caspi A; Elliott ML; Bourassa KJ; Chamarti K; Corcoran DL; Hariri AR; Houts RM; Kothari M; Kritchevsky S; Kuchel GA; Mill JS; Williams BS; Belsky DW; Moffitt TE;
    Neurology; 2022 Sep; 99(13):e1402-e1413. PubMed ID: 35794023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
    Sapkota S; Dixon RA
    J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Pathway-Specific Polygenic Risk Score Is Associated with Tau Pathology and Cognitive Decline.
    Sun Y; Wang M; Zhao Y; Hu K; Liu Y; Liu B;
    J Alzheimers Dis; 2022; 85(4):1745-1754. PubMed ID: 34958026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
    Tijms BM; Gobom J; Reus L; Jansen I; Hong S; Dobricic V; Kilpert F; Ten Kate M; Barkhof F; Tsolaki M; Verhey FRJ; Popp J; Martinez-Lage P; Vandenberghe R; Lleó A; Molinuevo JL; Engelborghs S; Bertram L; Lovestone S; Streffer J; Vos S; Bos I; ; Blennow K; Scheltens P; Teunissen CE; Zetterberg H; Visser PJ
    Brain; 2020 Dec; 143(12):3776-3792. PubMed ID: 33439986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of greenness and polygenic risk score of Alzheimer's disease on risk of cognitive impairment.
    Jin X; Shu C; Zeng Y; Liang L; Ji JS
    Sci Total Environ; 2021 Nov; 796():148767. PubMed ID: 34273838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.
    Tan CH; Bonham LW; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Yokoyama JS; Rabinovici GD; Miller BL; Yaffe K; Schellenberg GD; Kauppi K; Holland D; McEvoy LK; Kukull WA; Tosun D; Weiner MW; Sperling RA; Bennett DA; Hyman BT; Andreassen OA; Dale AM; Desikan RS;
    Brain; 2019 Feb; 142(2):460-470. PubMed ID: 30689776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Alzheimer's genetic loci with mild behavioral impairment.
    Andrews SJ; Ismail Z; Anstey KJ; Mortby M
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):727-735. PubMed ID: 30378268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.